Substance P fragments and striatal endogenous dopamine outflow: Interaction with substance P

Neuropeptides

Volumn 32, Issue 6, 1998, Pages 519-526

  Khan, S ^a   Sandhu, J ^a   Whelpton, R ^a   Michael Titus, A T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; ATROPINE; DOPAMINE; SUBSTANCE P;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CARBOXY TERMINAL SEQUENCE; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0032407007     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90080-4     Document Type: Article

References (61)

1. Matsas R, Fulcher IS, Kenny AJ, Turner AJ. Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc Natl Acad Sci USA 1983; 80: 3111-3115.
2. Skidgel R, Engelbrecht S, Johnson AR, Erdös ED. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 1982; 3: 851-857.
3. Blumberg S, Teichberg VI, Charli JL et al. Cleavage of substance P to an N-terminal tetrapeptide and a C-terminal heptapeptide by a post-proline cleaving enzyme from bovine brain. Brain Res 1980; 192: 477-486.
4. Oblin A, Danse MJ, Zivkovic B. Metalloendopeptidase (EC 3.4.24.11) but not angiotensin converting enzyme is involved in the inactivation of substance P by synaptic membranes of the rat substantia nigra. Life Sci 1989; 44: 1467-1474.
5. Sakurada T, Le Grèves P, Stewart J, Terenius L. Measurement of substance P metabolites in rat CNS. J Neurochem 1985; 44: 718-722.
6. Hall ME, Miley F, Stewart JM. The role of enzymatic processing in the biological actions of substance P. Peptides 1989; 10: 895-901.
7. Herrera-Marschitz M, Terenius L, Sakurada T et al. The substance P(1-7) fragment is a potent modulator of substance P actions in the brain. Brain Res 1990; 521: 316-320.
8. Sakurada T, Tan-No K, Yamada T et al. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice. Life Sci 1990; 47: 109-113.
9. Skilling SR, Smullin DH, Larson AA. Differential effects of C-and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord:potential role in nociception. J Neurosci 1990; 10: 1309-1318.
10. Hall ME, Stewart JM. The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release. Pharmac Biochem Behav 1991; 41: 75-78.
11. Bolam JP, Somogyi P, Takagi H et al. Localization of substance P-like immunoreactivity in neurons and nerve terminals in the neostriatum of the rat: a correlated light and electron microscopic study. J Neurocytol 1983; 12: 325-344.
12. Gerfen CR, Young WS 3rd. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 1988; 460: 161-167
13. Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann Rev Neurosci 1992; 15: 285-320.
14. Humpel C, Saria A. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra. Neurosci Lett 1989; 105: 159-163.
15. Lindefors N, Brodin E, Tossman U et al. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Exp Brain Res 1989; 74: 527-534.
16. 11]-substance P. Brain Res 1990; 531: 333-337
17. Quirion R, Shults CW, Moody TW et al. Autoradiographic distribution of substance P receptors in rat central nervous system. Nat, 1983; 303: 714-716.
18. Rothman RB, Herkenham M, Pert C et al. Visualization of rat brain receptors for the neuropeptide substance P. Brain Res 1984; 309: 47-54.
19. Mussap CJ, Geraghty DP, Burcher E. Tachykinin receptors: a radioligand binding perspective. J Neurochem 1993; 60: 1987-2009.
20. Baruch P, Artaud F, Godeheu G et al. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopamine neurons. Neuroscience 1988; 25: 889-898.
21. Reid MS, Herrera-Marschitz M, Hökfelt T et al. Effects of intranigral substance P and neurokinin A on striatal dopamine release -I. interactions with substance P antagonists. Neuroscience 1990; 36: 643-658.
22. Gauchy C, Desban M, Glowinski J, Kernel ML. Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [Pro9]substance P of the N-methyl-D-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum. Neuroscience 1996; 73: 929-939.
23. 3H]dopamine from rat striatal slices: a tetrodotoxin-sensitive process. Neuropharmacology 1986; 25: 1015-1021.
24. Tremblay L, Kemel ML, Desban M et al. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors. Proc Natl Acad Sci USA 1992; 89: 11214-11218.
25. Khan S, Brooks N, Whelpton R, Michael-Titus AT. Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum. Eur J Pharmacol 1995; 282: 229-233.
26. Khan S, Whelpton R, Michael-Titus AT. Evidence for modulatory effects of substance P fragments (1-4) and (8-11) on endogenous dopamine outflow in rat striatal slices. Neurosci Lett 1996; 205: 33-36.
27. Khan S, Grogan E, Whelpton R, Michael-Titus AT. N- and C-terminal substance P fragments modulate striatal dopamine outflow through a cholinergic link mediated by muscarinic receptors. Neuroscience 1996; 73: 919-927
28. Reid MS, Herrera-Marschitz M, Terenius L, Ungerstedt U. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments. Brain Res 1990; 526: 228-234.
29. Andrén PE, Caprioli RM. In vivo metabolism of substance P in rat striatum utilizing microdialysis/liquid chromatography/micro-electrospray mass spectrometry. J Mass Spect 1995; 30: 817-824.
30. Khan S, Whelpton R, Michael-Titus AT. Endogenous dopamine outflow from rat striatal slices in static and dynamic conditions. Neurosci Res Commun 1995; 16: 145-153.
31. Bar-Shavit Z, Goldman R, Stabinsky Y, et al. Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980; 94: 1445-1451.
32. Hall ME, Miley FB, Stewart JM. Modulation of blood pressure by substance P: opposite effects of N-terminal and C-terminal fragments on anaesthetized rats. Life Sci 1987; 40: 1909-1914.
33. Cridland RA, Henry JL. N- and C-terminal SP-fragments of substance P: spinal effects in the rat tail flick test. Brain Res Bull 1988; 20: 429-432.
34. Humpel C, Saria A, Regoli D. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism. Eur J Pharm 1991; 195: 107-114.
35. Kostel KL, Lunte SM. Evaluation of capillary electrophoresis with post-column derivatization and laser-induced fluorescence detection for the determination of substance P and its metabolites. J Chromatogr 1997; 695: 27-38.
36. Xu M, Mizobe F, Yamamoto T, Kato T. Differential effect of M1-and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Res 1989; 495: 232-242.
37. Arenas E, Alberch J, Perez-Navarro E et al. Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum. J Neurosci 1991; 11: 2332-2338.
38. 1 receptor antagonist. Eur J Pharmacol 1993; 250: 403-413.
39. 2 from bradykinin, by X-Pro dipeptidyl-aminopeptidase. Biochim Biophys Acta 1978; 525: 417-422.
40. Matsas R, Kenny AJ, Turner AJ. The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase 24.11. Biochem J 1984; 223: 433-440.
41. Igwe OJ, Kim DC, Seybold VS, Larson AA. Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes. J Neurosci 1990; 10: 3653-3663.
42. Kage R, Leeman SE, Boyd ND. Biochemical characterization of two different forms of the substance P receptor in rat submaxillary gland. J Neurochem 1993; 60: 347-351.
43. Mantyh PW, Rogers SD, Ghilardi JR et al. Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo. Brain Res 1996; 719: 8-13.
44. Ingi T, Kitajima Y, Minamitake Y, Nakanishi S. Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells. J Pharm exp Ther 1991; 238: 968-975.
45. Cascieri MA, Huang R-R C, Fong TM et al. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol Pharmacol 1992; 41: 1096-1099.
46. Pradier L, Menager J, Le Guern J et al. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P. Mol Pharmacol 1994; 45: 287-293.
47. Sagan S, Chassaing G, Pradier L, Lavielle S. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. J Pharm exp Ther 1996; 276: 1039-1048.
48. Steinberg R, Rodier D, Souilhac J et al. Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J Neurochem 1995; 65: 2543-2548.
49. Torrens Y, Saffroy M, Glowinski J, Beaujouan JC. Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder. Neuropeptides 1997; 31: 243-251.
50. Maggi CA, Schwartz TW. The dual nature of the tachykinin NK1 receptor. TIPS 1997; 18: 351-355.
51. Hastrup H, Schwartz TW. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis. FEBS Lett 1996; 399: 264-266.
52. Fong T, Huang CR, Yu H et al. Mutational analysis of neurokinin receptor function. Can J Physiol Pharmacol 1995; 73: 860-865.
53. Turcatti G, Zoffmann S, Lowe JA 3rd et al. Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands. J Biol Chem 1997; 272: 21167-21175.
54. Rosenkilde MM, Cahir M, Gether U et al. Mutations along transmembrane segments II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J Biol Chem 1994; 269: 28160-28164.
55. Schwartz TW. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Biol 1994; 5: 434-444.
56. Schwartz TW, Gether U, Schambye HT, Hjorth SA. Molecular mechanism of action of non-peptide ligands for peptide receptors. Curr Pharm Design 1995; 1: 325-342.
57. Yukhananov RY, Larson AA. An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord. Neurosci Lett 1994; 178: 163-166.
58. Tschöpe C, Jost N, Unger T, Culman J. Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats. Brain Res 1995; 690: 15-24.
59. Michael-Titus AT, Whelpton R, Stephens SM, Yau KW. Metabolism of substance P in rat striatum studied using a combination of high performance liquid chromatography (HPLC) and capillary electrophoresis. Br J Pharmacol 1997; 122: 79P.
60. Emmett MR, Andrén PE, Caprioli RM. Specific molecular mass detection of endogenously released neuropeptides using in vivo microdialysis/mass spectrometry. J Neurosci Meth 1995; 62: 141-147
61. Davis TP, Gillespie TJ, Konings PNM. Specificity of neurotensin metabolism by regional rat brain slices. J Neurochem 1992; 58: 608-617.